Exiqon A/S has announced that it has won the Ernst & Young Entrepreneur of the Year award in the category Biotech 2005.
The award is created to identify and acknowledge the successful and entrepreneurial Danish companies.
A minimum growth of 15% in sales as well as growth in staff is among the key nomination criteria.
Exiqon’s ProbeLibrary™ product as well as its miRCURY™ microRNA detection product line were key elements of growth of the company.
"We are very proud to receive this important award," says Lars Kongsbak, President and CEO of Exiqon.
"What we are seeing are the first results of Exiqon’s strategy to develop and market competitive products based on our LNA™ technology."
He adds, "We expect Exiqon’s revenue for 2005 to reach 5-6 million USD."
The Ernst & Young award follows a successful past year where the Exiqon CEO won the award as Biotech Builder of the year, and Exiqon was named among the Top 100 most Innovative companies worldwide by the magazine RedHerring.